Can Ondansetron 4mg PO Be Prescribed to a 4-Year-Old Child Weighing 14kg?
Yes, ondansetron 4mg orally is appropriate and FDA-approved for a 4-year-old child weighing 14kg, particularly for chemotherapy-induced nausea and vomiting. For this weight (14kg falls in the 15-23kg range), the FDA-approved dose is 4mg three times daily for moderately emetogenic chemotherapy 1.
FDA-Approved Pediatric Dosing
The FDA label provides clear weight-based dosing for children 4-11 years of age 1:
- For children weighing <15kg: 30mg per dose
- For children weighing 15-23kg: 45mg per dose
- For children weighing 23-40kg: 60mg per dose
- For children weighing >40kg: 75mg per dose
However, your 14kg patient falls just below the 15kg threshold, so technically the FDA-approved dose would be 30mg (not 4mg) for moderately emetogenic chemotherapy 1. The 4mg dose represents approximately 0.29mg/kg, which is within the studied range but not the standard FDA recommendation for this exact weight.
Context-Specific Considerations
For Gastroenteritis with Vomiting
If this is for acute gastroenteritis, a single dose of 0.15mg/kg (approximately 2mg for 14kg) has been extensively studied and proven effective 2, 3, 4. Research demonstrates that ondansetron reduces vomiting episodes and decreases the need for IV rehydration in children with gastroenteritis 2, 3. The dose range of 0.13-0.26mg/kg has been shown safe and effective 5.
Important caveat: While ondansetron reduces vomiting, some studies report 2-3 times higher rates of diarrhea as a side effect 6, which may prolong gastroenteritis symptoms even as vomiting improves.
For Chemotherapy-Induced Nausea
For moderately emetogenic chemotherapy in a 14kg child, the FDA recommends 4mg three times daily (given 30 minutes before chemotherapy, then at 4 and 8 hours after the first dose, continuing every 8 hours for 1-2 days post-chemotherapy) 1.
For Postoperative Nausea
There is no established FDA approval for ondansetron in preventing postoperative nausea in pediatric patients 1. The adult dose is 16mg given 1 hour before anesthesia induction, but pediatric dosing for this indication lacks sufficient evidence.
Safety Profile
Ondansetron is generally well-tolerated in children 7. The most common adverse effects include:
- Headache
- Constipation
- Diarrhea (particularly concerning in gastroenteritis)
Critical safety consideration: Ondansetron should not be used with apomorphine due to risk of profound hypotension and loss of consciousness 1.
Practical Recommendation
For a 4-year-old weighing 14kg, prescribe ondansetron based on the specific indication:
- Gastroenteritis: Single dose of 2mg (0.15mg/kg) is evidence-based and effective 2, 3
- Moderately emetogenic chemotherapy: 4mg three times daily per FDA guidance 1
- Highly emetogenic chemotherapy: Consider higher dosing with specialist consultation
The 4mg dose you're considering is reasonable for chemotherapy-related nausea but may be higher than necessary for gastroenteritis, where a 2mg single dose would be more appropriate and evidence-based.